A screening study on seven photocatalysts was performed to identify the best candidate for pharmaceutical products degradation in water. Photocatalysts were deposited as thin films through a sol-gel process and subsequent dip-coating on glass slides. The efficiency of each photocatalyst was assessed through the degradation of methylene blue first, and then, through the degradation of 15 different pharmaceutical products. Two main types of synthesis methods were considered: aqueous syntheses, where the reaction takes place in water, and organic syntheses, where reactions take place in an organic solvent and only a stoichiometric amount of water is added to the reaction medium. Photocatalysts synthesized via aqueous sol-gel routes showed relatively lower degradation efficiencies; however, the organic route required a calcination step at high temperature to form the photoactive crystalline phase, while the aqueous route did not. The best performances for the degradation of pharmaceuticals arose when Evonik P25 and silver nanoparticles were added to TiO₂, which was synthesized using an organic solvent. In the case of methylene blue degradation, TiO₂ modified with Evonik P25 and TiO₂ doped with MnO₂ nanoparticles were the two best candidates.
Keywords: TiO2; pharmaceutical products; photocatalysis; sol-gel process; thin films.